179 related articles for article (PubMed ID: 11211927)
1. Assay of cyclooxygenase-1 and 2 in human monocytes.
Demasi M; Caughey GE; James MJ; Cleland LG
Inflamm Res; 2000 Dec; 49(12):737-43. PubMed ID: 11211927
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
3. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
4. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of cyclooxygenase-2 by NS-398 in endotoxin shock rats in vivo.
Futaki N; Takahashi S; Kitagawa T; Yamakawa Y; Tanaka M; Higuchi S
Inflamm Res; 1997 Dec; 46(12):496-502. PubMed ID: 9459080
[TBL] [Abstract][Full Text] [Related]
6. Constitutive cyclooxygenase-1 and induced cyclooxygenase-2 in isolated human iris inhibited by S(+) flurbiprofen.
van Haeringen NJ; van Sorge AA; Carballosa Coré-Bodelier VM
J Ocul Pharmacol Ther; 2000 Aug; 16(4):353-61. PubMed ID: 10977131
[TBL] [Abstract][Full Text] [Related]
7. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages.
Matsumoto H; Naraba H; Murakami M; Kudo I; Yamaki K; Ueno A; Oh-ishi S
Biochem Biophys Res Commun; 1997 Jan; 230(1):110-4. PubMed ID: 9020023
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitors.
Penglis PS; Cleland LG; Demasi M; Caughey GE; James MJ
J Immunol; 2000 Aug; 165(3):1605-11. PubMed ID: 10903770
[TBL] [Abstract][Full Text] [Related]
9. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases.
Neupert W; Brugger R; Euchenhofer C; Brune K; Geisslinger G
Br J Pharmacol; 1997 Oct; 122(3):487-92. PubMed ID: 9351505
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Famaey JP
Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
[TBL] [Abstract][Full Text] [Related]
11. Development of an in-vitro test system for the evaluation of cyclooxygenase-2 inhibitors.
Laufer S; Zechmeister P; Klein T
Inflamm Res; 1999 Mar; 48(3):133-8. PubMed ID: 10219655
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
Duan W; Zhang L
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2-dependent prostaglandin production by peripheral blood monocytes stimulated with lipopolysaccharides isolated from periodontopathogenic bacteria.
Noguchi K; Yanai M; Shitashige M; Nishihara T; Ishikawa I
J Periodontol; 2000 Oct; 71(10):1575-82. PubMed ID: 11063390
[TBL] [Abstract][Full Text] [Related]
14. Expression and vascular effects of cyclooxygenase-2 in brain.
Brian JE; Moore SA; Faraci FM
Stroke; 1998 Dec; 29(12):2600-6. PubMed ID: 9836773
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages.
Barrios-Rodiles M; Keller K; Belley A; Chadee K
Biochem Biophys Res Commun; 1996 Aug; 225(3):896-900. PubMed ID: 8780708
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
[TBL] [Abstract][Full Text] [Related]
18. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
van Haeringen NJ; van Sorge AA; Van Delft JL; Carballosa Coré-Bodelier VM
J Ocul Pharmacol Ther; 2000 Aug; 16(4):345-52. PubMed ID: 10977130
[TBL] [Abstract][Full Text] [Related]
19. Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
Longo WE; Panesar N; Mazuski J; Kaminski DL
Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):325-39. PubMed ID: 9990676
[TBL] [Abstract][Full Text] [Related]
20. Effect of COX-1/COX-2 inhibition versus selective COX-2 inhibition on coronary vasodilator responses to arachidonic acid and acetylcholine.
Gross GJ; Moore J
Pharmacology; 2004 Jul; 71(3):135-42. PubMed ID: 15161995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]